Recent Advances in Functional MRI to Predict Treatment Response for Locally Advanced Rectal Cancer

1.

Gérard J-P, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(28):4620–5. https://doi.org/10.1200/JCO.2006.06.7629.

Article  Google Scholar 

2.

Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–40. https://doi.org/10.1056/NEJMoa040694.

CAS  Article  PubMed  Google Scholar 

3.

Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(16):1926–33. https://doi.org/10.1200/JCO.2011.40.1836.

CAS  Article  Google Scholar 

4.

Ngan SY, Burmeister B, Fisher RJ, et al. Randomized trial of short course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(31):3827–33. https://doi.org/10.1200/JCO.2012.42.9597.

Article  Google Scholar 

5.

Erlandsson J, Holm T, Pettersson D, et al. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol. 2017;18(3):336–46. https://doi.org/10.1016/S1470-2045(17)30086-4.

Article  PubMed  Google Scholar 

6.

Colorectal Cancer - Statistics. Cancer.Net. Published June 25, 2012. Accessed May 31, 2021. https://www.cancer.net/cancer-types/colorectal-cancer/statistics

7.

Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1):19–23.

CAS  Article  Google Scholar 

8.

Ryan R, Gibbons D, Hyland JMP, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47(2):141–6. https://doi.org/10.1111/j.1365-2559.2005.02176.x.

CAS  Article  PubMed  Google Scholar 

9.

Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer. 1994;73(11):2680–6. https://doi.org/10.1002/1097-0142(19940601)73:11%3c2680::aid-cncr2820731105%3e3.0.co;2-c.

CAS  Article  PubMed  Google Scholar 

10.

Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–46. https://doi.org/10.1056/NEJMoa010580.

CAS  Article  PubMed  Google Scholar 

11.

Janjan NA, Crane C, Feig BW, et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol. 2001;24(2):107–12.

CAS  Article  Google Scholar 

12.

Park IJ, You YN, Agarwal A, et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(15):1770–6. https://doi.org/10.1200/JCO.2011.39.7901.

CAS  Article  Google Scholar 

13.

Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711–717; discussion 717–718.

14.

Ellis CT, Samuel CA, Stitzenberg KB. National trends in nonoperative management of rectal adenocarcinoma. J Clin Oncol. Published online March 28, 2016:JCO642066. https://doi.org/10.1200/JCO.2015.64.2066

15.

Yang TJ, Goodman KA. Predicting complete response: is there a role for non-operative management of rectal cancer? J Gastrointest Oncol. 2015;6(2):241–6. https://doi.org/10.3978/j.issn.2078-6891.2014.110.

Article  PubMed  PubMed Central  Google Scholar 

16.

Pham TT, Liney GP, Wong K, Barton MB. Functional MRI for quantitative treatment response prediction in locally advanced rectal cancer. Br J Radiol. 2017;90(1072):20151078. https://doi.org/10.1259/bjr.20151078.

Article  PubMed  PubMed Central  Google Scholar 

17.

Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol. 2019;92(1096):20180655. https://doi.org/10.1259/bjr.20180655.

Article  PubMed  PubMed Central  Google Scholar 

18.

Fusco R, Petrillo M, Granata V, et al. Magnetic resonance imaging evaluation in neoadjuvant therapy of locally advanced rectal cancer: a systematic review. Radiol Oncol. 2017;51(3):252–62. https://doi.org/10.1515/raon-2017-0032.

Article  PubMed  PubMed Central  Google Scholar 

19.

Park SH, Cho SH, Choi SH, et al. MRI assessment of complete response to preoperative chemoradiation therapy for rectal cancer: 2020 guide for practice from the Korean Society of Abdominal Radiology. Korean J Radiol. 2020;21(7):812–28. https://doi.org/10.3348/kjr.2020.0483.

Article  PubMed  PubMed Central  Google Scholar 

20.

Malayeri AA, El Khouli RH, Zaheer A, et al. Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. Radiogr Rev Publ Radiol Soc N Am Inc. 2011;31(6):1773–91. https://doi.org/10.1148/rg.316115515.

Article  Google Scholar 

21.

Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A. 2005;102(15):5524–9. https://doi.org/10.1073/pnas.0501532102.

CAS  Article  PubMed  PubMed Central  Google Scholar 

22.

Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer Oxf Engl 1990. 2009;45(2):228–247. https://doi.org/10.1016/j.ejca.2008.10.026

23.

Lee MA, Cho SH, Seo AN, et al. Modified 3-point MRI-based tumor regression grade incorporating DWI for locally advanced rectal cancer. Am J Roentgenol. 2017;209(6):1247–55. https://doi.org/10.2214/AJR.16.17242.

Article  Google Scholar 

24.

Yoen H, Park HE, Kim SH, et al. Prognostic value of tumor regression grade on MR in rectal cancer: a large-scale, single-center experience. Korean J Radiol. 2020;21(9):1065–76. https://doi.org/10.3348/kjr.2019.0797.

Article  PubMed  PubMed Central  Google Scholar 

25.

Chandramohan A, Siddiqi UM, Mittal R, et al. Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Radiol Open. 2020;7. https://doi.org/10.1016/j.ejro.2020.100223

26.

van Heeswijk MM, Lambregts DMJ, Palm WM, et al. DWI for assessment of rectal cancer nodes after chemoradiotherapy: is the absence of nodes at DWI proof of a negative nodal status? Am J Roentgenol. 2016;208(3):W79–84. https://doi.org/10.2214/AJR.16.17117.

Article  Google Scholar 

27.

Gollub MJ, Das JP, Bates DDB, et al. Rectal cancer with complete endoscopic response after neoadjuvant therapy: what is the meaning of a positive MRI? Eur Radiol. Published online January 15, 2021. https://doi.org/10.1007/s00330-020-07657-0

28.

Shaverdian N, Yang Y, Hu P, et al. Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer. Br J Radiol. 2017;90(1071):20160739. https://doi.org/10.1259/bjr.20160739.

Article  PubMed  PubMed Central  Google Scholar 

29.

De Felice F, Magnante AL, Musio D, et al. Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2017;43(7):1324–9. https://doi.org/10.1016/j.ejso.2017.03.010.

Article  Google Scholar 

30.

Palmisano A, Di Chiara A, Esposito A, et al. MRI prediction of pathological response in locally advanced rectal cancer: when apparent diffusion coefficient radiomics meets conventional volumetry. Clin Radiol. 2020;75(10):798.e1-798.e11. https://doi.org/10.1016/j.crad.2020.06.023.

CAS  Article  Google Scholar 

31.

Yang L, Qiu M, Xia C, et al. Value of high-resolution DWI in combination with texture analysis for the evaluation of tumor response after preoperative chemoradiotherapy for locally advanced rectal cancer. AJR Am J Roentgenol. Published online March 12, 2019:1–8. https://doi.org/10.2214/AJR.18.20689

32.

Bassaneze T, Gonçalves JE, Faria JF, Palma RT, Waisberg J. Quantitative aspects of diffusion-weighted magnetic resonance imaging in rectal cancer response to neoadjuvant therapy. Radiol Oncol. 2017;51(3):270–6. https://doi.org/10.1515/raon-2017-0025.

CAS  Article  PubMed  PubMed Central  Google Scholar 

33.

Tarallo N, Angeretti MG, Bracchi E, et al. Magnetic resonance imaging in locally advanced rectal cancer: quantitative evaluation of the complete response to neoadjuvant therapy. Pol J Radiol. 2018;83:e600–9. https://doi.org/10.5114/pjr.2018.81156.

Article  PubMed  PubMed Central  Google Scholar 

34.

Crimì F, Stramare R, Spolverato G, et al. T2-weighted, apparent diffusion coefficient and 18F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy. Tech Coloproctol. 2021;25(5):569–77. https://doi.org/10.1007/s10151-021-02440-9.

Article  PubMed  PubMed Central  Google Scholar 

35.

Bulens P, Couwenberg A, Haustermans K, et al. Development and validation of an MRI-based model to predict response to chemoradiotherapy for rectal cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2018;126(3):437–42. https://doi.org/10.1016/j.radonc.2018.01.008.

Article  Google Scholar 

36.

Joye I, Debucquoy A, Deroose CM, et al. Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2017;124(1):104–9. https://doi.org/10.1016/j.radonc.2017.06.013.

Article  Google Scholar 

37.

Schurink NW, Min LA, Berbee M, et al. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation. Eur Radiol. 2020;30(5):2945–54. https://doi.org/10.1007/s00330-019-06638-2.

Article  PubMed  Google Scholar 

38.

•• Tang Z, Zhang X-Y, Liu Z, et al. Quantitative analysis of diffusion weighted imaging to predict pathological good response to neoadjuvant chemoradiation for locally advanced rectal cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2019;132:100–8. https://doi.org/10.1016/j.radonc.2018.11.007. A large patient cohort study (152 training and 70 validation) investigating the usage of radiomics and clinical characteristics for LARC down-staging prediction.

Article  Google Scholar 

39.

Bulens P, Couwenberg A, Intven M, et al. Predicting the tumor response to chemoradiotherapy for rectal cancer: model development and external validation using MRI radiomics. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2020;142:246–52. https://doi.org/10.1016/j.radonc.2019.07.033.

CAS  Article  Google Scholar 

40.

Chen F, Ma X, Li S, et al. MRI-based radiomics of rectal cancer: assessment of the local recurrence at the site of anastomosis. Acad Radiol. Published online November 5, 2020. https://doi.org/10.1016/j.acra.2020.09.024

41.

Wan L, Peng W, Zou S, et al. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Acad Radiol. Published online November 11, 2020. https://doi.org/10.1016/j.acra.2020.10.026

42.

van Griethuysen JJM, Lambregts DMJ, Trebeschi S, et al. Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer. Abdom Radiol. 2020;45(3):632–43. https://doi.org/10.1007/s00261-019-02321-8.

Article  Google Scholar 

43.

Nardone V, Reginelli A, Scala F, et al. Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation. Gastroenterol Res Pract. 2019;2019:e8505798. https://doi.org/10.1155/2019/8505798.

Article  Google Scholar 

44.

Fu J, Zhong X, Li N, et al. Deep learning-based radiomic features for improving neoadjuvant chemoradiation response prediction in locally advanced rectal cancer. Phys Med Biol. 2020;65(7):075001. https://doi.org/10.1088/1361-6560/ab7970.

Article  PubMed  Google Scholar 

45.

Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2015;278(2):563–77. https://doi.org/10.1148/radiol.2015151169.

Article  PubMed  Google Scholar 

46.

Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497–505. https://doi.org/10.1148/radiology.168.2.3393671.

留言 (0)

沒有登入
gif